Annual ROE
21.05%
-2.06%-8.91%
December 31, 2023
Summary
- As of February 12, 2025, CORT annual return on equity is 21.05%, with the most recent change of -2.06% (-8.91%) on December 31, 2023.
- During the last 3 years, CORT annual ROE has fallen by -2.65% (-11.18%).
- CORT annual ROE is now -81.06% below its all-time high of 111.15%, reached on December 31, 2017.
Performance
CORT ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
25.77%
+0.91%+3.66%
September 30, 2024
Summary
- As of February 12, 2025, CORT quarterly return on equity is 25.77%, with the most recent change of +0.91% (+3.66%) on September 30, 2024.
- Over the past year, CORT quarterly ROE has increased by +1.85% (+7.73%).
- CORT quarterly ROE is now -91.42% below its all-time high of 300.37%, reached on June 30, 2004.
Performance
CORT Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
CORT ROE Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -8.9% | +7.7% |
3 y3 years | -11.2% | +11.8% |
5 y5 years | -34.9% | +11.8% |
CORT ROE Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -15.9% | at low | -1.2% | +34.7% |
5 y | 5-year | -27.7% | at low | -17.4% | +34.7% |
alltime | all time | -81.1% | +105.9% | -91.4% | +104.3% |
Corcept Therapeutics Incorporated ROE History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | 25.77%(+3.7%) |
Jun 2024 | - | 24.86%(+3.9%) |
Mar 2024 | - | 23.92%(+9.1%) |
Dec 2023 | 21.05%(-8.9%) | 21.92%(+14.6%) |
Sep 2023 | - | 19.13%(-4.2%) |
Jun 2023 | - | 19.97%(-0.4%) |
Mar 2023 | - | 20.06%(-12.9%) |
Dec 2022 | 23.11%(-7.7%) | 23.04%(-11.7%) |
Sep 2022 | - | 26.09%(+5.9%) |
Jun 2022 | - | 24.63%(+3.8%) |
Mar 2022 | - | 23.72%(+4.3%) |
Dec 2021 | 25.03%(+5.6%) | 22.75%(+10.5%) |
Sep 2021 | - | 20.58%(+5.4%) |
Jun 2021 | - | 19.52%(-6.2%) |
Mar 2021 | - | 20.82%(-11.7%) |
Dec 2020 | 23.70%(-18.6%) | 23.59%(-11.2%) |
Sep 2020 | - | 26.57%(-13.1%) |
Jun 2020 | - | 30.56%(-2.0%) |
Mar 2020 | - | 31.19%(+3.7%) |
Dec 2019 | 29.11%(-9.9%) | 30.09%(+0.8%) |
Sep 2019 | - | 29.86%(+4.0%) |
Jun 2019 | - | 28.70%(-3.6%) |
Mar 2019 | - | 29.78%(-6.4%) |
Dec 2018 | 32.31%(-70.9%) | 31.82%(-58.2%) |
Sep 2018 | - | 76.21%(-17.2%) |
Jun 2018 | - | 92.09%(-21.2%) |
Mar 2018 | - | 116.89%(-21.4%) |
Dec 2017 | 111.15%(+308.8%) | 148.63%(+130.7%) |
Sep 2017 | - | 64.42%(+13.9%) |
Jun 2017 | - | 56.58%(+51.6%) |
Mar 2017 | - | 37.33%(+25.6%) |
Dec 2016 | 27.19%(-132.1%) | 29.72%(+44.0%) |
Sep 2016 | - | 20.64%(+180.1%) |
Jun 2016 | - | 7.37%(-168.5%) |
Mar 2016 | - | -10.76%(-83.0%) |
Dec 2015 | -84.82%(-76.2%) | -63.21%(-65.3%) |
Sep 2015 | - | -182.41%(-54.4%) |
Jun 2015 | - | -399.78%(-32.9%) |
Mar 2015 | - | -596.12%(+10.7%) |
Dec 2014 | -356.04%(+220.3%) | -538.58%(+76.6%) |
Sep 2014 | - | -305.01%(+47.2%) |
Jun 2014 | - | -207.23%(+32.1%) |
Mar 2014 | - | -156.87%(+39.8%) |
Date | Annual | Quarterly |
---|---|---|
Dec 2013 | -111.15%(+41.1%) | -112.25%(+24.7%) |
Sep 2013 | - | -90.01%(+6.9%) |
Jun 2013 | - | -84.23%(+10.5%) |
Mar 2013 | - | -76.20%(-3.7%) |
Dec 2012 | -78.79%(-31.7%) | -79.15%(-4.6%) |
Sep 2012 | - | -82.93%(-5.5%) |
Jun 2012 | - | -87.74%(+8.0%) |
Mar 2012 | - | -81.25%(+3.1%) |
Dec 2011 | -115.44%(-3.7%) | -78.83%(+8.8%) |
Sep 2011 | - | -72.45%(-15.0%) |
Jun 2011 | - | -85.23%(-5.1%) |
Mar 2011 | - | -89.80%(-28.8%) |
Dec 2010 | -119.84%(+15.9%) | -126.16%(+26.6%) |
Sep 2010 | - | -99.62%(-12.3%) |
Jun 2010 | - | -113.55%(-12.8%) |
Mar 2010 | - | -130.29%(+2.9%) |
Dec 2009 | -103.42%(-18.4%) | -126.65%(-5.5%) |
Sep 2009 | - | -134.09%(+16.2%) |
Jun 2009 | - | -115.42%(+20.0%) |
Mar 2009 | - | -96.16%(+4.6%) |
Dec 2008 | -126.80%(+15.6%) | -91.97%(+12.5%) |
Sep 2008 | - | -81.76%(+3.2%) |
Jun 2008 | - | -79.20%(+7.2%) |
Mar 2008 | - | -73.90%(-18.3%) |
Dec 2007 | -109.73%(-27.3%) | -90.43%(-9.7%) |
Sep 2007 | - | -100.09%(-28.6%) |
Jun 2007 | - | -140.14%(-19.1%) |
Mar 2007 | - | -173.31%(+2.1%) |
Dec 2006 | -150.96%(+99.8%) | -169.75%(+8.2%) |
Sep 2006 | - | -156.90%(+43.3%) |
Jun 2006 | - | -109.51%(+48.0%) |
Mar 2006 | - | -73.99%(+24.8%) |
Dec 2005 | -75.56%(+123.5%) | -59.31%(+13.9%) |
Sep 2005 | - | -52.07%(+19.1%) |
Jun 2005 | - | -43.71%(+13.5%) |
Mar 2005 | - | -38.50%(-26.9%) |
Dec 2004 | -33.81%(-208.4%) | -52.65%(-56.2%) |
Sep 2004 | - | -120.28%(-140.0%) |
Jun 2004 | - | 300.37%(+921.7%) |
Mar 2004 | - | 29.40%(-5.7%) |
Dec 2003 | 31.18%(-63.0%) | 31.18% |
Dec 2002 | 84.34%(-353.2%) | - |
Dec 2001 | -33.31% | - |
FAQ
- What is Corcept Therapeutics Incorporated annual return on equity?
- What is the all time high annual ROE for Corcept Therapeutics Incorporated?
- What is Corcept Therapeutics Incorporated annual ROE year-on-year change?
- What is Corcept Therapeutics Incorporated quarterly return on equity?
- What is the all time high quarterly ROE for Corcept Therapeutics Incorporated?
- What is Corcept Therapeutics Incorporated quarterly ROE year-on-year change?
What is Corcept Therapeutics Incorporated annual return on equity?
The current annual ROE of CORT is 21.05%
What is the all time high annual ROE for Corcept Therapeutics Incorporated?
Corcept Therapeutics Incorporated all-time high annual return on equity is 111.15%
What is Corcept Therapeutics Incorporated annual ROE year-on-year change?
Over the past year, CORT annual return on equity has changed by -2.06% (-8.91%)
What is Corcept Therapeutics Incorporated quarterly return on equity?
The current quarterly ROE of CORT is 25.77%
What is the all time high quarterly ROE for Corcept Therapeutics Incorporated?
Corcept Therapeutics Incorporated all-time high quarterly return on equity is 300.37%
What is Corcept Therapeutics Incorporated quarterly ROE year-on-year change?
Over the past year, CORT quarterly return on equity has changed by +1.85% (+7.73%)